Clinical Trial Update: Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating idalopirdine in patients with mild-to-moderate Alzheimer's disease already treated with donepezil has completed; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)
• Idalopirdine (idalopirdine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-02-20